Your browser doesn't support javascript.
loading
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
Gordon, Nicolas; Gallagher, Peter T; Neupane, Neermala Poudel; Mandigo, Amy C; McCann, Jennifer K; Dylgjeri, Emanuela; Vasilevskaya, Irina; McNair, Christopher; Paller, Channing J; Kelly, Wm Kevin; Knudsen, Karen E; Shafi, Ayesha A; Schiewer, Matthew J.
Affiliation
  • Gordon N; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Gallagher PT; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Neupane NP; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Mandigo AC; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • McCann JK; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Dylgjeri E; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Vasilevskaya I; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • McNair C; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Paller CJ; Department of Oncology, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Kelly WK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Knudsen KE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Shafi AA; Department of Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Schiewer MJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
bioRxiv ; 2023 Mar 23.
Article in En | MEDLINE | ID: mdl-36993449

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: BioRxiv Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: BioRxiv Year: 2023 Document type: Article